chr16-67436149-G-GC
Variant names: 
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000196.4(HSD11B2):c.664+16dupC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,564,162 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0010   (  0   hom.,  cov: 31) 
 Exomes 𝑓:  0.0014   (  3   hom.  ) 
Consequence
 HSD11B2
NM_000196.4 intron
NM_000196.4 intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  -0.349  
Publications
0 publications found 
Genes affected
 HSD11B2  (HGNC:5209):  (hydroxysteroid 11-beta dehydrogenase 2) There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010] 
HSD11B2 Gene-Disease associations (from GenCC):
- apparent mineralocorticoid excessInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 16-67436149-G-GC is Benign according to our data. Variant chr16-67436149-G-GC is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 723515.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.001 (151/150936) while in subpopulation EAS AF = 0.00293 (15/5118). AF 95% confidence interval is 0.00181. There are 0 homozygotes in GnomAd4. There are 78 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. 
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| HSD11B2 | ENST00000326152.6 | c.664+7_664+8insC | splice_region_variant, intron_variant | Intron 3 of 4 | 1 | NM_000196.4 | ENSP00000316786.5 | |||
| HSD11B2 | ENST00000567684.2 | n.527+7_527+8insC | splice_region_variant, intron_variant | Intron 3 of 3 | 3 | |||||
| HSD11B2 | ENST00000566606.1 | n.*472_*473insC | downstream_gene_variant | 5 | ENSP00000473429.1 | 
Frequencies
GnomAD3 genomes  0.000995  AC: 150AN: 150828Hom.:  0  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
150
AN: 
150828
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00340  AC: 715AN: 210458 AF XY:  0.00197   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
715
AN: 
210458
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00143  AC: 2024AN: 1413226Hom.:  3  Cov.: 36 AF XY:  0.00142  AC XY: 999AN XY: 703968 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2024
AN: 
1413226
Hom.: 
Cov.: 
36
 AF XY: 
AC XY: 
999
AN XY: 
703968
show subpopulations 
African (AFR) 
 AF: 
AC: 
61
AN: 
32438
American (AMR) 
 AF: 
AC: 
43
AN: 
43838
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2
AN: 
25370
East Asian (EAS) 
 AF: 
AC: 
134
AN: 
38324
South Asian (SAS) 
 AF: 
AC: 
101
AN: 
84868
European-Finnish (FIN) 
 AF: 
AC: 
376
AN: 
50646
Middle Eastern (MID) 
 AF: 
AC: 
6
AN: 
5536
European-Non Finnish (NFE) 
 AF: 
AC: 
1231
AN: 
1073960
Other (OTH) 
 AF: 
AC: 
70
AN: 
58246
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.402 
Heterozygous variant carriers
 0 
 109 
 217 
 326 
 434 
 543 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 46 
 92 
 138 
 184 
 230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00100  AC: 151AN: 150936Hom.:  0  Cov.: 31 AF XY:  0.00106  AC XY: 78AN XY: 73722 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
151
AN: 
150936
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
78
AN XY: 
73722
show subpopulations 
African (AFR) 
 AF: 
AC: 
44
AN: 
41212
American (AMR) 
 AF: 
AC: 
3
AN: 
15148
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3436
East Asian (EAS) 
 AF: 
AC: 
15
AN: 
5118
South Asian (SAS) 
 AF: 
AC: 
6
AN: 
4770
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10390
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
82
AN: 
67586
Other (OTH) 
 AF: 
AC: 
1
AN: 
2074
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.476 
Heterozygous variant carriers
 0 
 7 
 15 
 22 
 30 
 37 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Apparent mineralocorticoid excess    Benign:1 
Sep 28, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.